{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib7dc3abapcppc2qfkvq74pz7lqj76hbzfwuydt7soavem3hqh364",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mixkvbuehkv2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic5udpt2q5sqluo64tfde7gwfo46jrqlllrgshc7ol7lh74gmoqqy"
    },
    "mimeType": "image/jpeg",
    "size": 111846
  },
  "path": "/pharmalot/2026/04/07/merck-experimental-hiv-prevention-pill-made-for-five-dollars-year/?utm_campaign=rss",
  "publishedAt": "2026-04-07T10:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "drug pricing",
    "HIV/AIDS",
    "Pharmaceuticals",
    "public health",
    "STAT+"
  ],
  "textContent": "Resarchers say Merck should 'urgently begin licensing generic production to its HIV prevention pill.",
  "title": "STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say",
  "updatedAt": "2026-04-07T11:35:51.000Z"
}